Elanco Animal Health
ELAN
485 hedge funds and large institutions have $12.2B invested in Elanco Animal Health in 2025 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 152 increasing their positions, 148 reducing their positions, and 40 closing their positions.
205% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 40
18% more funds holding
Funds holding: 410 → 485 (+75)
6% more capital invested
Capital invested by funds: $11.5B → $12.2B (+$699M)
3% more repeat investments, than reductions
Existing positions increased: 152 | Existing positions reduced: 148
6.46% less ownership
Funds ownership: 114.96% → 108.49% (-6.5%)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
48% less call options, than puts
Call options by funds: $29.5M | Put options by funds: $56.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$80.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$80.3M |
| 3 |
Millennium Management
New York
|
+$54.6M |
| 4 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$53.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$51.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$286M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$170M |
| 3 |
Primecap Management
Pasadena,
California
|
-$81.5M |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$80M |
| 5 |
FGP
Freestone Grove Partners
San Francisco,
California
|
-$77.4M |
ELAN Hedge Fund Activity: Q4 2025 in Review
485 institutional investors reported a position in Elanco Animal Health (ELAN) for Q4 2025, worth a combined $12.2B — up 6.1% from $11.5B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new ELAN positions and 40 closed out — a net gain of 82 holders — while 152 added to existing stakes and 148 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $80.9M. The largest seller was Fidelity Investments, cutting an estimated $286M.
- 485 institutional investors held Elanco Animal Health (ELAN) as of Q4 2025, up from 410 in Q3 2025.
- Funds reported $12.2B of Elanco Animal Health stock for Q4 2025, up 6.1% quarter-over-quarter.
- 122 funds opened new Elanco Animal Health positions in Q4 2025 and 40 closed out, a net change of +82 holders.
- The largest Elanco Animal Health buyer in Q4 2025 was T. Rowe Price Investment Management, an estimated $80.9M added.
- The largest Elanco Animal Health seller in Q4 2025 was Fidelity Investments, an estimated $286M sold.
Based on aggregated 13F filings for Q4 2025.